Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL

Ann Pharmacother. 2004 Feb;38(2):351-2. doi: 10.1345/aph.1D004. Epub 2003 Dec 23.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Catheterization, Central Venous*
  • Equipment Failure
  • Humans
  • Plasminogen Activators / therapeutic use*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Plasminogen Activators
  • Tissue Plasminogen Activator